Enfortumab vedotin is one of the recent additions when it comes to new and latest FDA approved drugs. This is a more specific reference to cancer care medicines recommended for…
Tukysa in India – Tucatinib for HER2 Positive Breast Cancer Treatment
Tucatinib is an antineoplastic drug which also comes under the classification of Tyrosine Kinase Inhibitors. This is one of the emerging treatment options for metastatic breast cancer therapy. Tucatinib has…
Selpercatinib in India – Retevmo for Lung and Thyroid Cancer Treatment
Selpercatinib, a kinase inhibitor by its composition works by blocking the enzyme kinase and eventually prevents the proliferation of cancer cells. Oncologists recommend this drug based on the data available…
Cemiplimab in India – Libtayo for the treatment of squamous cell skin cancer
Cemiplimab is duly approved by the US FDA. Its key indication is cutaneous squamous cell carcinoma. It is also indicated in basal cell carcinoma and non-small cell lung cancer management….
Clinical recommendations of Venclexta and ways to access Venetoclax in India
Venetoclax is an oral medication recommended by Hematologists across the world, predominantly USA and Europe. It is duly approved as a treatment option in the management of Chronic Lymphocytic Leukemia…
Mylotarg in India – Gemtuzumab for acute myeloid leukemia treatment
Gemtuzumab ozogamicin, an antibody–drug conjugate is also a progressive medication to treat leukemia patients. Predominantly identified for its effectiveness as a treatment option in the management of acute myeloid leukemia,…